UNC researchers find new genetic target for a different kind of cancer drug

Researchers from the UNC School of Medicine have discovered that the protein RBM4, a molecule crucial to the process of gene splicing, is drastically decreased in multiple forms of human cancer, including lung and breast cancers. The finding offers a new route toward therapies that can thwart the altered genetic pathways that allow cancer cells to proliferate and spread. Read more here.